1,665,540 new cancer cases are expected to be diagnosed in 2014 and the NIH estimates that the overall costs of cancer in 2009 were $216.6 billion.Learn More
Improve patient outcomes and reduce costs associated with inappropriate (or suboptimal) therapeutic regimens.Learn More
Our goal is to enable physicians to diagnose disease at an earlier stage and to make treatment decisions based on the best response to therapy.Learn More

Solutions for Oncology Prognosis and Companion Diagnostics

The Oncology Challenge Around 1,665,540 new cancer cases are expected to be diagnosed worldwide in 2014 and cancer is currently the second most common cause of death in the United States. Surgical
Learn More
Companion diagnostics identify those patients who are most likely to respond to therapy and provide information on disease predisposition, prognosis and the likelihood of treatment response. Developmental cost of a new molecular
Learn More
EMAP technology encapsulates functionalized magnetic nanoparticles inside a variable electromagnetic field to deliver significant improvements in speed and sensitivity in multiplexed bioassays. Electromagnetically activated particle
Learn More
Site by Kwok Design